MOLECULAR CHARACTERIZATION OF THE RHODOPSIN GENE
MOLECULAR CHARACTERIZATION OF THE RHODOPSIN GENE
批准号:
3263130
负责人:
JAMES Francis MCGINNIS
金额:
$22.49万
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-07-01 至 1994-06-30
关键词:
RNA splicing alleles animal population genetics gene expression gene mutation genetic mapping genetic models genetic transcription genetic transduction hybrid cells immunocytochemistry in situ hybridization laboratory mouse laboratory rabbit laboratory rat lens proteins messenger RNA molecular cloning nucleic acid sequence posttranscriptional RNA processing regulatory gene retinal adaptation retinoid binding proteins rhodopsin transcription factor transfection visual photoreceptor
中文摘要
视紫红质基因结构特征与
调控其表达的分子机制,
和感光细胞的存活是重要的神经生物学
这些问题相对来说知之甚少。 总体目标
这5年的研究计划是表征分子结构
和小鼠视紫红质基因的功能。 这包括对
其表达受遗传和环境(光与
暗)因素及其控制机制的研究
在正常小鼠和遗传性小鼠发育过程中的表达
视觉缺陷。 视蛋白和48 k(S-抗原,
Arrestin)以非协调的方式受到光和/或
光/暗周期,动物暴露于其中。 此外该
视杆细胞中许多感光细胞特异性蛋白的定位
内段和外段是瞬态的并且依赖于光。 的
mRNA浓度变化与
光感受器特异性蛋白质与发育,基因型,
将通过西方和北方分析以及
免疫细胞化学 小鼠视蛋白基因已经被克隆,
测序,并证明了推定的调控序列。 顺式
核苷酸序列和反式作用因子,它们参与
光介导的反应将使用DNA阻滞试验来鉴定
和转染研究。 基因的确切染色体位点
小鼠视紫红质和48 k将使用Southern分析来确定,
中国仓鼠-小鼠体细胞基因组DNA限制性内切酶分析
细胞杂交和来自小鼠的重组近交系。 结构
这些基因的表达将在突变小鼠中进行检测
其映射在其位点处或附近。 的核苷酸序列
将确定所鉴定的视紫红质基因的等位基因形式,
视紫红质基因的定性和定量活性
单独测定这些基因,以及与突变(rd)组合测定
和RDS),其引起遗传性视网膜变性和转录
以及对视蛋白基因表达的转录后效应,
在感光细胞死亡之前。 分子结构
小鼠视紫红质基因的五个转录本的功能将
在正常和突变小鼠中测定。 由此产生的数据
项目可以增加我们对正常过程的理解,
人类的光传导和/或遗传性
视网膜变性
英文摘要
The relationship of the structural features of the rhodopsin gene and
the molecular mechanisms regulating its expression, to phototransduction
and to the survival of photoreceptor cells are important neurobiological
problems about which relatively little is known. The overall objective
of this 5 year research plan is to characterize the molecular structure
and function of the mouse rhodopsin gene. This includes studies on the
regulation of its expression by genetic and environmental (light vs.
dark) factors and the investigation of the mechanisms controlling its
expression during development of normal mice and of mice with inherited
visual defects. The amounts of mRNA for opsin and 48k (S-antigen,
Arrestin) are regulated in a non-coordinate manner by light and/or the
light/dark cycle to which the animal is exposed. In addition, the
localization of a number of photoreceptor specific proteins in the rod
inner and outer segments is transient and dependent on light. The
relationship between the changes in concentration of mRNAs and
photoreceptor specific proteins with respect to development, genotype,
and light will be determined by Western and Northern analysis and by
immunocytochemistry. The mouse opsin gene has been cloned and
sequenced, and putative regulatory sequence demonstrated. Cis-acting
nucleotide sequences and trans-acting factors which participate in the
light mediated responses will be identified using DNA retardation assays
and transfection studies. The exact chromosomal loci for the genes for
mouse rhodopsin and 48k will be determined using Southern analysis of
restriction digests of genomic DNA from Chinese hamster-mouse somatic
cell hybrids and from recombinant inbred lines of mice. The structure
and expression of these genes will be examined in mice with mutations
which map at or near to their loci. The nucleotide sequences of
identified allelic forms of the rhodopsin gene will be determined and
the qualitative and quantitative activity of the rhodopsin gene
determined for these genes alone, and in combination with mutations (rd
and rds) which cause inherited retinal degeneration and transcriptional
and post transcriptional effects on the expression of the opsin gene,
prior to the death of the photoreceptor cells. The molecular structure
and function of the five transcripts from the mouse rhodopsin gene will
be determined in normal and mutant mice. The data generated by this
project may increase our understanding of the normal process of
phototransduction in man and/or the molecular pathology of inherited
retinal degeneration.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Prolonged Inhibition of Pathologic Neovascularization by Catalytic Antioxidants
-
批准号:8607958
-
项目类别:
-
资助金额:$53.69万
-
财政年份:2012
-
负责人:JAMES Francis MCGINNIS
-
依托单位:
Prolonged Inhibition of Pathologic Neovascularization by Catalytic Antioxidants
-
批准号:8222309
-
项目类别:
-
资助金额:$58.36万
-
财政年份:2012
-
负责人:JAMES Francis MCGINNIS
-
依托单位:
Prolonged Inhibition of Pathologic Neovascularization by Catalytic Antioxidants
-
批准号:8415878
-
项目类别:
-
资助金额:$52.24万
-
财政年份:2012
-
负责人:JAMES Francis MCGINNIS
-
依托单位:
Prolonged Inhibition of Pathologic Neovascularization by Catalytic Antioxidants
-
批准号:8798665
-
项目类别:
-
资助金额:$53.75万
-
财政年份:2012
-
负责人:JAMES Francis MCGINNIS
-
依托单位:
Cellular Imaging and Morphometric Analysis Core
-
批准号:10011811
-
项目类别:
-
资助金额:$21.47万
-
财政年份:2011
-
负责人:JAMES Francis MCGINNIS
-
依托单位:
COBRE:OUHSC: IMAGE ACQUISITION & PRODUCTION CORE
-
批准号:8360403
-
项目类别:
-
资助金额:$22.66万
-
财政年份:2011
-
负责人:JAMES Francis MCGINNIS
-
依托单位:
COBRE:OUHSC: IMAGE ACQUISITION & PRODUCTION CORE
-
批准号:8168347
-
项目类别:
-
资助金额:$21.89万
-
财政年份:2010
-
负责人:JAMES Francis MCGINNIS
-
依托单位:
Prevention of Inherited Retinal Diseases by Therapeutic Rare Earth Nanoparticles
-
批准号:7583201
-
项目类别:
-
资助金额:$37.48万
-
财政年份:2009
-
负责人:JAMES Francis MCGINNIS
-
依托单位:
COBRE:OUHSC: IMAGE ACQUISITION & PRODUCTION CORE
-
批准号:7959974
-
项目类别:
-
资助金额:$21.04万
-
财政年份:2009
-
负责人:JAMES Francis MCGINNIS
-
依托单位:
Prevention of Inherited Retinal Diseases by Therapeutic Rare Earth Nanoparticles
-
批准号:7895588
-
项目类别:
-
资助金额:$36.32万
-
财政年份:2009
-
负责人:JAMES Francis MCGINNIS
-
依托单位:
COBRE:OUHSC: IMAGE ACQUISITION & PRODUCTION CORE
-
批准号:7720537
-
项目类别:
-
资助金额:$19.51万
-
财政年份:2008
-
负责人:JAMES Francis MCGINNIS
-
依托单位:
Pharmacokinetics of Therapeutic Nanoparticles in the CNS
-
批准号:7475063
-
项目类别:
-
资助金额:$18.04万
-
财政年份:2007
-
负责人:JAMES Francis MCGINNIS
-
依托单位:
Pharmacokinetics of Therapeutic Nanoparticles in the CNS
-
批准号:7279508
-
项目类别:
-
资助金额:$19.24万
-
财政年份:2007
-
负责人:JAMES Francis MCGINNIS
-
依托单位:
COBRE:OUHSC: IMAGE ACQUISITION & PRODUCTION CORE
-
批准号:7610503
-
项目类别:
-
资助金额:$10.32万
-
财政年份:2007
-
负责人:JAMES Francis MCGINNIS
-
依托单位:
Pharmacokinetics of Therapeutic Nanoparticles in the CNS
-
批准号:7659516
-
项目类别:
-
资助金额:$18.24万
-
财政年份:2007
-
负责人:JAMES Francis MCGINNIS
-
依托单位:
COBRE:OUHSC: IMAGE ACQUISITION & PRODUCTION CORE
-
批准号:7381942
-
项目类别:
-
资助金额:$9.81万
-
财政年份:2006
-
负责人:JAMES Francis MCGINNIS
-
依托单位:
COBRE:OUHSC: IMAGE ACQUISITION & PRODUCTION CORE
-
批准号:7171162
-
项目类别:
-
资助金额:$6.79万
-
财政年份:2005
-
负责人:JAMES Francis MCGINNIS
-
依托单位:
COBRE:OUHSC: IMAGE ACQUISITION & PRODUCTION CORE
-
批准号:6982239
-
项目类别:
-
资助金额:$7.88万
-
财政年份:2004
-
负责人:JAMES Francis MCGINNIS
-
依托单位:
CORE--IMAGE ACQUISTION & ANALYSIS
-
批准号:6985856
-
项目类别:
-
资助金额:$21.93万
-
财政年份:2004
-
负责人:JAMES Francis MCGINNIS
-
依托单位:
CORE--IMAGE ACQUISITION AND PRODUCTION
-
批准号:6630577
-
项目类别:
-
资助金额:$11.7万
-
财政年份:2002
-
负责人:JAMES Francis MCGINNIS
-
依托单位:
海外基金